Literature DB >> 12237331

Down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation by inhibitor of 90-kDa heat-shock protein family: endoplasmic reticulum retention of monomeric insulin receptor precursor with calnexin in adrenal chromaffin cells.

Tomokazu Saitoh1, Toshihiko Yanagita, Seiji Shiraishi, Hiroki Yokoo, Hideyuki Kobayashi, Shin-Ichi Minami, Toshio Onitsuka, Akihiko Wada.   

Abstract

Treatment (>/=6 h) of cultured bovine adrenal chromaffin cells with geldanamycin (GA) or herbimycin A (HA), an inhibitor of the 90-kDa heat-shock protein (Hsp90) family, decreased cell surface (125)I-insulin binding. The effect of GA was concentration (EC(50) = 84 nM)- and time (t(1/2) = 8.5 h)-dependent; GA (1 microM for 24 h) lowered the B(max) value of (125)I-insulin binding by 80%, without changing the K(d) value. Western blot analysis showed that GA (>/=3 h) lowered insulin receptor (IR) level by 83% (t(1/2) = 7.4 h; EC(50) = 74 nM), while raising IR precursor level by 100% (t(1/2) = 7.9 h; EC(50) = 300 nM). Pulse-label followed by reducing and nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that monomeric IR precursor (~190 kDa) developed into the homodimeric IR precursor (approximately 380 kDa) and the mature alpha(2)beta(2) IR (~410 kDa) in nontreated cells, but not in GA-treated cells; in GA-treated cells, the homodimerization-incompetent form of monomeric IR precursor was degraded via endoplasmic reticulum (ER)-associated protein degradation. Immunoprecipitation followed by immunoblot analysis showed that IR precursor was associated with calnexin (CNX) to a greater extent in GA-treated cells, compared with nontreated cells. GA had no effect on IR mRNA levels and internalization rate of cell surface IRs. In GA-treated cells, insulin-induced tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) was attenuated by 77%, with no change in IRS-1 level. Thus, inhibition of the Hsp90 family by GA or HA interrupts homodimerization of monomeric IR precursor in the ER and increases retention of monomeric IR precursor with CNX; this event retards cell surface expression of IR and attenuates insulin-induced activation of IRS-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237331     DOI: 10.1124/mol.62.4.847

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

Review 1.  The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?

Authors:  Martin McLaughlin; Koen Vandenbroeck
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

3.  UBC9-dependent association between calnexin and protein tyrosine phosphatase 1B (PTP1B) at the endoplasmic reticulum.

Authors:  Dukgyu Lee; Allison Kraus; Daniel Prins; Jody Groenendyk; Isabelle Aubry; Wen-Xin Liu; Hao-Dong Li; Olivier Julien; Nicolas Touret; Brian D Sykes; Michel L Tremblay; Marek Michalak
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

4.  Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene.

Authors:  K Højlund; J F P Wojtaszewski; J Birk; B F Hansen; H Vestergaard; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-06-08       Impact factor: 10.122

5.  Hsp83/Hsp90 Physically Associates with Insulin Receptor to Promote Neural Stem Cell Reactivation.

Authors:  Jiawen Huang; Hongyan Wang
Journal:  Stem Cell Reports       Date:  2018-09-20       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.